People Skip Cancer Treatments Drugs Because Of High Prices

University of Alberta study sheds light on defect behind multiple sclerosis
March 30, 2017
Why isn’t this solution to the spread of Hep C being used here?
March 30, 2017
Show all

People Skip Cancer Treatments Drugs Because Of High Prices

Cancer patients increasingly delay or skip taking medication because they can’t afford it. New drugs that can cost $100,000 or more a year mean more people suffering “financial toxicity.”

John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger.

The doctor recommended a drug called Alecensa, which sells for more than $159,000 a year. Medicare would charge Krahne a $3,200 copay in December, then another $3,200 in January, as a new year of coverage kicked in.

For the first time since being diagnosed 10 years ago, Krahne, 65, decided to delay filling his prescription, hoping that his cancer wouldn’t take advantage of the lapse and wreak further havoc on his body.

With new cancer drugs commonly priced at $100,000 a year or more, Krahne’s story is becoming increasingly common. Hundreds of thousands of cancer patients are delaying care, cutting their pills in half or skipping drug treatment entirely, a Kaiser Health News examination shows.

One-quarter of all cancer patients chose not to fill a prescription due to cost, according to a 2013 study in The Oncologist. And about 20 percent filled only part of a prescription or took less than the prescribed amount. Given that more than 1.6 million Americans are likely to be diagnosed with cancer this year, that suggests 168,000 to 405,000 ration their own prescription use.

Read full article: People Skip Cancer Treatments Drugs Because Of High Prices : Shots – Health News : NPR

Read Full Article: People Skip Cancer Treatments Drugs Because Of High Prices : Shots – Health News : NPR

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.